Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole

Christophe Fontaine; Philippe Bousquet; Pascal Demoly

doi:10.1016/j.jaci.2004.10.045

Retour

Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole

Article de revue

Avec comité de lecture

Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole

Christophe Fontaine, Philippe Bousquet et Pascal Demoly

Journal of allergy and clinical immunology, Vol.115(3), pp.633-634

01/03/2005

DOI: https://doi.org/10.1016/j.jaci.2004.10.045

PMID: 15753917

Résumé

Allergies

Drug dosages

Drug therapy

Nonsteroidal anti-inflammatory drugs

No symptoms occurred after the full therapeutic dose administration. Because of the sulfonamide structure of celecoxib,3 we performed a third OPT with cotrimoxazole (sulfametoxazole+trimetoprime). [...]it underlines the importance of a thorough drug allergy work-up, allowing the reintroduction of other coxibs.

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole
Créateurs - sans rôle: Christophe Fontaine
Philippe Bousquet
Pascal Demoly
Détails de publication: Journal of allergy and clinical immunology, Vol.115(3), pp.633-634
Éditeur: Elsevier Limited
Identifiants: 99150229009311
Unité académique: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Langue: English
Type de ressource: Journal article